Cancers, Free Full-Text
Por um escritor misterioso
Descrição
Imatinib became the standard treatment for chronic myeloid leukemia (CML) about 20 years ago, which was a major breakthrough in stabilizing the pathology and improving the quality of life of patients. However, the emergence of resistance to imatinib and other tyrosine kinase inhibitors leads researchers to characterize new therapeutic targets. Several studies have highlighted the role of histone deacetylase 6 (HDAC6) in various pathologies, including cancer. This protein effectively intervenes in cellular activities by its primarily cytoplasmic localization. In this review, we will discuss the molecular characteristics of the HDAC6 protein, as well as its overexpression in CML leukemic stem cells, which make it a promising therapeutic target for the treatment of CML.
Cancer
100% Cancer Free sticker — Perch Handmade
PDF) Predictors of recurrence free survival for patients with stage II and III colon cancer
Cancer Free – Heaven Sent Greeting Cards
Pancreatic Cancer Action Network – Research, Patient Support, Resources
Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization
Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort study
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization
Download or order free information booklets
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study.
de
por adulto (o preço varia de acordo com o tamanho do grupo)
